Israeli biopharmaceutical company Mileutis has completed clinical trials of a new antimicrobial substitute that improves the quality of milk in dairy cows. The trials were carried out on seven Israeli dairy farms, involving over 500 cows. The results showed an increase in protein and fat content in the milk, as well as an increase in milk yield, which could impact milk prices and benefit the consumer market.